Silgan Holdings’s (NYSE:SLGN) Q2 CY2026: Beats On Revenue

Silgan Holdings (NYSE:SLGN) reported Q2 CY2026 results with revenue up 6.8% year on year to $1.64 billion, topping Wall Street’s revenue estimate by 1.9%, according to the company and consensus. Non-GAAP adjusted EPS was $0.98, 1.9% above analysts’ estimates. Full-year EPS guidance is expected to rise from $3.65 to $3.91.

Original reporting
Published Jul 29, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 12:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Silgan Holdings’s (NYSE:SLGN) Q2 CY2026: Beats On Revenue — source image
Decision brief

The 30-second read

$SLGNBullishMed
01

Why it matters

Q2 results beat revenue and adjusted EPS, but the article highlights declining operating margin and weaker year-on-year EPS, plus slightly missed next-quarter EPS guidance, creating a mixed setup for near-term positioning.

02

Market read

Traders can reassess SLGN’s near-term earnings power based on the beat, while monitoring margin pressure and the next-quarter EPS guidance miss.

03

What to watch

The text cites full-year EPS guidance in line with estimates but does not quantify cash flow, backlog, or customer contract timing, which could dominate the next earnings cycle.

Relevance 6/10Novelty 6/10Timing: after-hours or immediately following Q2 CY2026 results, with stock noted flat at $47.81

Background

Silgan is a rigid packaging supplier (metal containers, closures, plastic packaging) and reported Q2 CY2026 results versus Wall Street expectations.

Company-level read

Ticker impact

$SLGNBullishMedium confidence
Context

Silgan Holdings reported Q2 CY2026 revenue of $1.64B (+6.8% YoY) and non-GAAP EPS of $0.98, beating revenue and consensus EPS.

Expected impact

Likely modest positive bias for SLGN as traders digest the beat, with follow-through dependent on next-quarter EPS guidance and margin trajectory.

Evidence & confidence

The article provides concrete Q2 results versus consensus and notes operating margin and EPS declined year over year, plus next-quarter EPS guidance slightly missed.

Market effects

Rigid packaging demand and pricing power read-through may improve slightly if SLGN’s above-consensus revenue growth persists.

No specific regional demand or macro driver is disclosed.

No direct global supply-chain or international regulatory catalyst is mentioned.

Counterpoint

The beat may be less durable because operating margin fell year over year and the article flags expense pressure and a slightly missed next-quarter EPS guidance.

Key entities

  • Silgan Holdings

    Rigid packaging manufacturer reporting Q2 CY2026 revenue and adjusted EPS versus consensus, with commentary on margins and guidance.

  • Adam Greenlee

    President and CEO quoted on operational execution and strategic growth initiatives for 2026.

Related articles

$SLGNMed

Silgan Holdings Inc. Q2 2026 Earnings Call Summary

Strategic Performance Drivers Management attributed Q2 performance to strong execution in high-value segments like fine fragrance and wet pet food, which helped offset geopolitical and inflationary headwinds. Dispensing and Specialty Closures (DSC) faced a 15% volume decline in Brazil due to inflationary market conditions, though management views this as a temporary market dynamic rather than a loss of share.

$SLGNMed

Silgan Q2 Earnings Call Highlights

Fabry said the combination of Brazil volume weakness and less favorable mix reduced second-quarter results by about $5 million. Despite that impact, adjusted EBIT in the segment was comparable with the prior year as favorable price over cost offset the volume and mix pressure. Greenlee highlighted continued strong growth in fine-fragrance dispensing products, particularly in Europe.

$SLGNMed

Silgan Q2 profit slips despite higher sales

Silgan has posted a net income of $75.8m for the second quarter (Q2) of 2026, down from $89m in the same period of 2025. Quarterly sales reached $1.64bn, an increase of $104.1m, or 7%, from a year earlier. Discover B2B Marketing That Performs Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

$SLGNMedAI 8/10

Silgan (SLGN) Q2 2026 Earnings Call Transcript

Silgan (SLGN) held its Q2 2026 earnings call, reporting net sales of about $1.6 billion, up 7% year over year, and adjusted EPS of $0.98. Adjusted EPS was below the prior year due to lower adjusted EBIT. The company confirmed 2026 adjusted EPS guidance of $3.73 to $3.93 and gave Q3 2026 adjusted EPS guidance of $1.21 to $1.31.

$SLGNMed

SILGAN HOLDINGS INC (SLGN): Results of Operations and Financial Condition

SILGAN HOLDINGS INC (SLGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991_63026.htm EX-99.1 Document Silgan Holdings Inc. Exhibit 99.1 SILGAN ANNOUNCES SECOND QUARTER 2026 RESULTS H ighlights • Achieved high single digit volume growth in dispensing products for fragrance markets • Delivered high single digit volume growth in metal contai